Associate Medical Director

Responsibilities

• Serve as Global Medical Advisor for assigned clinical trials, focusing on early phase oncology and hematology studies (Phase I–II)
• Provide medical and scientific guidance to Project Leaders and clinical project teams throughout study delivery
• Support investigative sites with protocol-related issues, including eligibility determinations and patient safety assessments
• Perform medical review of key study documents such as protocols, Investigator’s Brochures (IB), and Case Report Forms (CRFs)
• Conduct medical review of trial-related Adverse Events (AEs) and Serious Adverse Events (SAEs) in collaboration with Pharmacovigilance
• Review Clinical Study Reports (CSRs) and patient narratives
• Support business development activities, including proposal input, medical feasibility assessments, and client bid defenses
• Build and maintain strong working relationships with sponsors, investigators, and internal stakeholders

Requirements

• Medical degree (MD or equivalent) from an accredited and internationally recognized medical school
• Current or prior medical license to practice medicine
• 5–7+ years of post-graduate clinical experience
• Demonstrated experience in early phase oncology or hematology clinical trials
• Strong knowledge of global and local regulatory requirements, including GCP, ICH, TGA, FDA, and EMA
• High level of scientific and clinical judgment with strong communication and stakeholder engagement skills

Preferred Qualifications

• Specialist training and clinical experience as an Oncologist and/or Hematologist
• Board certification or equivalent specialist recognition in oncology or hematology
• Prior industry or clinical research experience
• Experience in medical monitoring and safety oversight within a CRO or biopharmaceutical setting

About the Company

IQVIA is a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.